New targets for glioblastoma, which are believed to drive the grow and recurrence of this brain tumor, have been identified.
An ovarian cancer biomarker that may help in predicting the treatment response and improve outcomes for patients with the epithelial form of the disease, has been discovered.
Research on brain cancer stem cells has identified immune system targets, and even an experimental vaccine.
Cancer metastasis from the breast to the brain may be due to a protein, according to new research.
A biomarker for Esophageal Squamous Cell Carcinoma (ESCC) has been discovered, which can help diagnosis, prognosis and treatment of this disease.
The risk of dying from cancer was found 20% lower among postmenopausal women who followed guidance on diet, weight, physical activity, and alcohol intake.
Cancer treatments face resistance for various reasons, and researchers are focusing on a suppressor protein that may kill cancer cells.
Thyroid cancer diagnosed in minorities and people of low socioeconomic status is more likely to be at advanced stage.
Prostate cancer is over-diagnosed in 42% of cases, leading to unnecessary treatment and side-effects. Now a tool is being developed against that trend.
Cervical cancer diagnosis and stage indication via a blood-based test has been demonstrated, which can help in prompt treatment.
Melanoma metastases can be diagnosed, staged and treated more effectively through a new radiopharmaceutical technique.
A skin cancer (melanoma) treatment combination from GlaxoSmithKline has won accelerated approval from US regulators.
Non Small Cell Lung Cancer (NSCLC) treatment outcomes may be substantially improved through a new type of immunotherapy.
Researchers analyzed the structure of a cervical cancer related protein (called E6AP) in high detail.
Cancerous behavior in high-risk lung cells was increased when exposed to electronic cigarette vapor in a lab setting.
Glioblastoma multiforme is the most common and most aggressive form of brain cancer. Scientists identified a new gene behind this tumor, which may be a target for new treatments.
Cancer patients may have sleep problems or even insomnia due to pain or side effects, and two behavioral interventions may help them overcome them.
Diet and nutrition may affect genes driving cancer cell growth, and researchers are exploring impact on prevention and treatment.
Prostate cancer growth and metastasis depends on a particular genome variant, according to new research which can improve understanding of prostate cancer risk.
A mutated gene in rare brain tumors (craniopharyngiomas) has been identified, possibly leading to better treatment. The cancer is currently treated with surgeries & radiation.
Patients treated for kidney cancer with robot-assisted partial nephrectomy & have chronic kidney disease preserved kidney function, even better than those without chronic kidney disease.
Research on neuroblastoma cells showed a substance (ellagic acid, found in red berries and nuts for instance) may be the basis for future treatment for this childhood cancer.
Genetic mutations related with multiple myeloma cells appear more complicated than thought before, perhaps affecting treatment strategies for this type of cancer.
Head and neck cancer patients receiving intensity-modulated radiation therapy (IMRT) experience fewer side effects and have better overall survival compared to standard radiotherapy.
Pediatric leukemia may be related to a cellular mechanism which, instead of fighting infection, rearranges DNA and may cause cancer.
Gene mutations related to pancreatic cancer may be detected by a blood tests, without a biopsy, according to the latest research.
Researchers shift focus to prostate tumor genomic analysis to identify the best treatment among radiation, surgery, or other therapy.
Screening via Computed Tomography (CT) and an antigen, each had improved rate of surgical treatment of colon cancer recurrence, compared with minimal follow-up.
Advanced gastric cancer patients' survival was prolonged with a combination of an experimental angiogenesis inhibitor and chemotherapy, in a large trial.
Breast cancer stem cells were shown to be responsible for metastasis in specific ways. This discovery may enable the use of markers towards more effective treatments.